Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

Data as of Jan 23
 +0.03 / +1.45%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Alexza Pharmaceuticals, Inc. is a pharmaceutical company, which is focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system, or CNS, conditions. The company's product candidates are based on its proprietary technology, the Staccato system. Its lead product candidate is ADASUVE, which is being developed for the acute treatment of agitation in adults with schizophrenia or bipolar disorder. The company's other product candidates, which are in clinical stage includes AZ-007, Staccato nicotine, AZ-10, AZ-002 and AZ-002. It was formerly known as Alexza Molecular Delivery Corp. and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals was founded by Alejandro C. Zaffaroni on December 19, 2000 and is headquartered in Mountain View, CA.

Contact Information

Alexza Pharmaceuticals, Inc.
2091 Stierlin Court
Mountain View California 94303
P:(650) 944-7000
Investor Relations:



Individual stakeholders8.33%
Other institutional26.71%
Mutual fund holders10.66%

Top Executives

Thomas Braxton KingPresident, Chief Executive Officer & Director
Robert A. LippeChief Operations Officer & Executive VP-Operations
Mark K. OkiChief Financial Officer & SVP-Finance
James V. CassellaCSO, Executive VP-Research & Development
Tatjana NarandaVP-Business Development & Alliance Management

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.